Company Overview

PRIME exits and American Health Care Capital are proud to present an International Medical Device Regulatory Consulting Group for sale. The company is an association of consultants with many years of experience in establishing quality systems and attaining market clearance for medical device companies in the US, Canada, and European regulatory markets. Their team of professionals have experience developing and defending quality systems in companies whose sizes range from Fortune 100 worldwide companies to start-ups trying to get their first product approved by FDA. They have an international presence with customers in Asia, Europe, and the Americas.

Financial Overview

Over the last few years, the company has remained steady in volume, profitability, and client base. In 2019, Gross revenues were $362,621 with an adjusted EBITDA of $103,295. In 2020, Gross Revenues were $497,512 with an adjusted EBITDA of $184,921. In 2021, Gross Revenues were $441,466 with an adjusted EBITDA of $142,865. In 2022 for the first ten months, they had Revenue of $394,534 and an adjusted EBITDA of approximately $105,669, and they expect to gross $475,000 by the end of the year with an adjusted EBITDA of around $150,000.

Staff Overview

This company has a very stable office and field staff that are all expected to stay on post-sale. The owner wishes to sell to pursue other business interests but will assist during a transitional period.

Asking Price

The asking price for this international medical device consultant is $300,000.